Besides, elevation of CST1 is a promising diagnostic biomarker for other cancer types, including pancreatic cancer (Jiang et al., 2015), esophageal squamous cell carcinoma (Chen et al., 2013), and gastric cancer (Choi et al., 2009). Here, CST1 is linked to pancreatic neoplasm.